Literature DB >> 30266628

Continuous Renal Replacement Therapy: Who, When, Why, and How.

Srijan Tandukar1, Paul M Palevsky2.   

Abstract

Continuous renal replacement therapy (CRRT) is commonly used to provide renal support for critically ill patients with acute kidney injury, particularly patients who are hemodynamically unstable. A variety of techniques that differ in their mode of solute clearance may be used, including continuous venovenous hemofiltration with predominantly convective solute clearance, continuous venovenous hemodialysis with predominantly diffusive solute clearance, and continuous venovenous hemodiafiltration, which combines both dialysis and hemofiltration. The present article compares CRRT with other modalities of renal support and reviews indications for initiation of renal replacement therapy, as well as dosing and technical aspects in the management of CRRT. Published by Elsevier Inc.

Entities:  

Keywords:  acute kidney injury; continuous renal replacement therapy; dialysis; hemodialysis; hemofiltration

Mesh:

Year:  2018        PMID: 30266628      PMCID: PMC6435902          DOI: 10.1016/j.chest.2018.09.004

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  98 in total

Review 1.  Timing of initiation of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis.

Authors:  Xuan Wang; Wei Jie Yuan
Journal:  Ren Fail       Date:  2012-01-20       Impact factor: 2.606

Review 2.  Haemodialysis-associated anaphylactic and anaphylactoid reactions.

Authors:  D G Ebo; J L Bosmans; M M Couttenye; W J Stevens
Journal:  Allergy       Date:  2006-02       Impact factor: 13.146

3.  Clinical Complications of Continuous Renal Replacement Therapy.

Authors:  Florent Sigwalt; Axelle Bouteleux; François Dambricourt; Théo Asselborn; Florent Moriceau; Thomas Rimmelé
Journal:  Contrib Nephrol       Date:  2018-03-29       Impact factor: 1.580

4.  We Lower Blood Flow for Intradialytic Hypotension.

Authors:  Richard A Sherman
Journal:  Semin Dial       Date:  2016-04-15       Impact factor: 3.455

5.  Acute renal failure in critically ill patients: a multinational, multicenter study.

Authors:  Shigehiko Uchino; John A Kellum; Rinaldo Bellomo; Gordon S Doig; Hiroshi Morimatsu; Stanislao Morgera; Miet Schetz; Ian Tan; Catherine Bouman; Ettiene Macedo; Noel Gibney; Ashita Tolwani; Claudio Ronco
Journal:  JAMA       Date:  2005-08-17       Impact factor: 56.272

6.  Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure.

Authors:  Filipe S Cardoso; Michelle Gottfried; Shannan Tujios; Jody C Olson; Constantine J Karvellas
Journal:  Hepatology       Date:  2017-12-26       Impact factor: 17.425

7.  Intensity of renal support in critically ill patients with acute kidney injury.

Authors:  Paul M Palevsky; Jane Hongyuan Zhang; Theresa Z O'Connor; Glenn M Chertow; Susan T Crowley; Devasmita Choudhury; Kevin Finkel; John A Kellum; Emil Paganini; Roland M H Schein; Mark W Smith; Kathleen M Swanson; B Taylor Thompson; Anitha Vijayan; Suzanne Watnick; Robert A Star; Peter Peduzzi
Journal:  N Engl J Med       Date:  2008-05-20       Impact factor: 91.245

8.  Citrate anticoagulation for continuous venovenous hemofiltration.

Authors:  Heleen M Oudemans-van Straaten; Rob J Bosman; Matty Koopmans; Peter H J van der Voort; Jos P J Wester; Johan I van der Spoel; Lea M Dijksman; Durk F Zandstra
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

9.  Timing of initiation of dialysis in critically ill patients with acute kidney injury.

Authors:  Kathleen D Liu; Jonathan Himmelfarb; Emil Paganini; T Alp Ikizler; Sharon H Soroko; Ravindra L Mehta; Glenn M Chertow
Journal:  Clin J Am Soc Nephrol       Date:  2006-07-06       Impact factor: 8.237

10.  Intensity of renal replacement therapy in acute kidney injury: perspective from within the Acute Renal Failure Trial Network Study.

Authors:  Paul M Palevsky; Theresa Z O'Connor; Glenn M Chertow; Susan T Crowley; Jane Hongyuan Zhang; John A Kellum
Journal:  Crit Care       Date:  2009-08-11       Impact factor: 9.097

View more
  35 in total

1.  Population Pharmacokinetics and Dosing Optimization of Gentamicin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.

Authors:  Sha He; Zeneng Cheng; Feifan Xie
Journal:  Drug Des Devel Ther       Date:  2022-01-06       Impact factor: 4.162

2.  Survey of Physiotherapy Practice in Ontario Cardiac Surgery Intensive Care Units.

Authors:  Anastasia N L Newman; Michelle E Kho; Jocelyn E Harris; Alison Fox-Robichaud; Patricia Solomon
Journal:  Physiother Can       Date:  2021-06-07       Impact factor: 1.037

3.  Pharmacokinetics of Commonly Used Medications in Children Receiving Continuous Renal Replacement Therapy: A Systematic Review of Current Literature.

Authors:  Samuel Dubinsky; Kevin Watt; Steven Saleeb; Bilal Ahmed; Caitlin Carter; Cindy H T Yeung; Andrea Edginton
Journal:  Clin Pharmacokinet       Date:  2021-11-30       Impact factor: 6.447

4.  Refractoriness of Hyperkalemia and Hyperphosphatemia in Dialysis-Dependent AKI Associated with COVID-19.

Authors:  Swetha R Kanduri; Akanksh Ramanand; Vipin Varghese; Yuang Wen; Muner M B Mohamed; Juan Carlos Q Velez
Journal:  Kidney360       Date:  2022-05-18

Review 5.  Dose of Continuous Renal Replacement Therapy in Critically Ill Patients: A Bona Fide Quality Indicator.

Authors:  Enzo Vásquez Jiménez; Samaya J Anumudu; Javier A Neyra
Journal:  Nephron       Date:  2021-02-04       Impact factor: 2.847

6.  Continuous Venovenous Hemofiltration is Associated with Improved Survival in Burn Patients with Shock: A Subset Analysis of a Multicenter Observational Study.

Authors:  David M Hill; Julie A Rizzo; James K Aden; William L Hickerson; Kevin K Chung
Journal:  Blood Purif       Date:  2020-12-02       Impact factor: 2.614

7.  Optimizing Antimicrobial Dosing for Critically Ill Patients with MRSA Infections: A New Paradigm for Improving Efficacy during Continuous Renal Replacement Therapy.

Authors:  Jiaojiao Chen; Sihan Li; Quanfang Wang; Chuhui Wang; Yulan Qiu; Luting Yang; Ruiying Han; Qian Du; Lei Chen; Yalin Dong; Taotao Wang
Journal:  Pharmaceutics       Date:  2022-04-11       Impact factor: 6.525

8.  Clinical effect and safety of continuous renal replacement therapy in the treatment of neonatal sepsis-related acute kidney injury.

Authors:  Cheng Cai; Gang Qiu; Wenchao Hong; Yunlin Shen; Xiaohui Gong
Journal:  BMC Nephrol       Date:  2020-07-18       Impact factor: 2.388

Review 9.  Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?

Authors:  Catalin Constantinescu; Sergiu Pasca; Tiberiu Tat; Patric Teodorescu; Catalin Vlad; Sabina Iluta; Delia Dima; Dana Tomescu; Ecaterina Scarlatescu; Alina Tanase; Olafur Eysteinn Sigurjonsson; Anca Colita; Hermann Einsele; Ciprian Tomuleasa
Journal:  J Immunother Cancer       Date:  2020-05       Impact factor: 13.751

Review 10.  Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy.

Authors:  Lu Li; Xin Li; Yanzhe Xia; Yanqi Chu; Haili Zhong; Jia Li; Pei Liang; Yishan Bu; Rui Zhao; Yun Liao; Ping Yang; Xiaoyang Lu; Saiping Jiang
Journal:  Front Pharmacol       Date:  2020-05-29       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.